Insider Transactions in Q1 2021 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2021
|
Julia G. Butchko Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,500
+47.81%
|
-
|
|
Mar 19
2021
|
Rita Jain Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
109,365
+45.81%
|
-
|
|
Mar 19
2021
|
Michael James Elliott Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
97,600
+50.0%
|
-
|
|
Mar 19
2021
|
Connealy Pamela Yanchik Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,200
+50.0%
|
-
|
|
Mar 19
2021
|
Peter Salzmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
132,500
+50.0%
|
-
|
|
Mar 19
2021
|
Andrew J. Fromkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,500
+27.83%
|
-
|
|
Mar 19
2021
|
Douglas J. Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,500
+27.83%
|
-
|
|
Mar 19
2021
|
Atul Pande Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,500
+27.83%
|
-
|
|
Mar 19
2021
|
Frank Torti Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,200
+28.74%
|
-
|
|
Mar 19
2021
|
George V Migausky Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,500
+20.48%
|
-
|
|
Jan 22
2021
|
Rita Jain Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|